000 01231 a2200361 4500
005 20250512055906.0
264 0 _c19861016
008 198610s 0 0 eng d
022 _a0162-0886
024 7 _a10.1093/clinids/8.supplement_3.s315
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aGerberding, J L
245 0 0 _aLimitations of animal models in predicting beta-lactam efficacy for endocarditis and meningitis.
_h[electronic resource]
260 _bReviews of infectious diseases
_c
300 _aS315-8 p.
_bdigital
500 _aPublication Type: Journal Article; Review
650 0 4 _aAnimals
650 0 4 _aAnti-Bacterial Agents
_xmetabolism
650 0 4 _aDisease Models, Animal
650 0 4 _aDrug Evaluation, Preclinical
650 0 4 _aEndocarditis, Bacterial
_xdrug therapy
650 0 4 _aGuinea Pigs
650 0 4 _aHumans
650 0 4 _aKinetics
650 0 4 _aMeningitis, Haemophilus
_xdrug therapy
650 0 4 _aMice
650 0 4 _aRabbits
650 0 4 _aRats
650 0 4 _abeta-Lactams
700 1 _aSande, M A
773 0 _tReviews of infectious diseases
_gvol. 8 Suppl 3
_gp. S315-8
856 4 0 _uhttps://doi.org/10.1093/clinids/8.supplement_3.s315
_zAvailable from publisher's website
999 _c3535054
_d3535054